$VTVT News Article - vTv Therapeutics to Present Study Update and Preliminary Data on Baseline Characteristics of Study Participants in Phase 2 Elevage Study Evaluating Azeliragon at 13th Clinical Trials on Alzheimer's Disease (CTAD) Digital Event
https://marketwirenews.com/news-releases/vtv-...36386.html